IRCT20120624010104N7尚未招募未知
Evaluation of bioequivalency of Ursodeoxycholic acid capsule of Ahran Tejarat Company compared to Ursoflor® on 24 volunteers.
Ahran Tejarat Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •Complete clinical health
- •Age 18 to 60 years
- •Male volunteers
排除标准
- •Underlying diseases
- •Hypertension
- •Liver and gastrointestinal diseases
- •Smoking and alcohol consumption
- •Chronic drug use
- •Temporary drug use less than 10 days after sampling
研究者
相似试验
招募中
Unknown
Bioequivalence study of 300 mg ursodeoxycholic acid capsulesIn the present study, no disease was investigated..IRCT20230222057495N5Chemidarou Pharmaceutical Company24
招募中
Unknown
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N64Tabriz University of Medical Sciences24
招募中
不适用
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N16Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg tabletIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N30Tabriz University of Medical Sciences24
招募中
不适用
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIRCT20210519051345N25Tabriz University of Medical Sciences24